Novel pyridine and pyrimidine derivatives as promising anticancer agents: A review

[Display omitted] Pyridines and pyrimidines are the class of heterocyclic nitrogenous compounds having plethora of applications in anticancer drug development. These synthetic sources serve as the potent class of compounds in treatment of breast cancer, myeloid leukemia, pancreatic cancer, liver can...

Full description

Saved in:
Bibliographic Details
Published in:Arabian journal of chemistry 2022-06, Vol.15 (6), p.103846, Article 103846
Main Authors: Albratty, Mohammed, Alhazmi, Hassan Ahmad
Format: Article
Language:English
Subjects:
Anticancer
Drugs
In silico
In vitro
Pyridine
Pyrimidine
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c418t-42ec5f70b84a45bc64573fdef69b2fa0628ba1f9f0be62df895ab9a68faca0103
cites cdi_FETCH-LOGICAL-c418t-42ec5f70b84a45bc64573fdef69b2fa0628ba1f9f0be62df895ab9a68faca0103
container_end_page
container_issue 6
container_start_page 103846
container_title Arabian journal of chemistry
container_volume 15
creator Albratty, Mohammed
Alhazmi, Hassan Ahmad
description [Display omitted] Pyridines and pyrimidines are the class of heterocyclic nitrogenous compounds having plethora of applications in anticancer drug development. These synthetic sources serve as the potent class of compounds in treatment of breast cancer, myeloid leukemia, pancreatic cancer, liver cancer and idiopathic respiratory fibrosis etc. The present review enumerates the results of studies published during past three years (2019–2021) on pyridine and pyrimidine analogues with their respective anticancer properties characterized in vitro or through in silico studies and illustrates their potential in development of anticancer agents. Recent advances on pyridine and pyrimidine analogues mentioned in this review add to the appealing opportunities for cancer therapy.
doi_str_mv 10.1016/j.arabjc.2022.103846
format article
fullrecord <record><control><sourceid>elsevier_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_0f6cafb415b74217906f497b413edcce</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1878535222001629</els_id><doaj_id>oai_doaj_org_article_0f6cafb415b74217906f497b413edcce</doaj_id><sourcerecordid>S1878535222001629</sourcerecordid><originalsourceid>FETCH-LOGICAL-c418t-42ec5f70b84a45bc64573fdef69b2fa0628ba1f9f0be62df895ab9a68faca0103</originalsourceid><addsrcrecordid>eNp9kF9LwzAUxYMoOKffwId-gc0kTZPWB2EM_wyGguhzuElvRsrWjqRU9u3NVtmjT8k93PvjnEPIPaNzRpl8aOYQwDR2zinnScpLIS_IhJWqnBW5qi7P_4Jfk5sYG0oVpbmckM_3bsBttj8EX_sWM2jr07AbxxqDH6D3A8YMYrYP3c5H327SXu8ttBZDBhts-_iYLbKAg8efW3LlYBvx7u-dku-X56_l22z98bpaLtYzK1jZzwRHWzhFTSlAFMZKUajc1ehkZbgDKnlpgLnKUYOS166sCjAVyNKBBZpCTslq5NYdNHqfPEM46A68Pgld2GgIyeUWNXXSgjOCFUYJzlRFpROVSkKOtbWYWGJk2dDFGNCdeYzqY8e60WPH-tixHjtOZ0_jGaacKXvQ0XpMrdQ-oO2TEf8_4BdZkohj</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Novel pyridine and pyrimidine derivatives as promising anticancer agents: A review</title><source>ScienceDirect®</source><source>Full-Text Journals in Chemistry (Open access)</source><creator>Albratty, Mohammed ; Alhazmi, Hassan Ahmad</creator><creatorcontrib>Albratty, Mohammed ; Alhazmi, Hassan Ahmad</creatorcontrib><description>[Display omitted] Pyridines and pyrimidines are the class of heterocyclic nitrogenous compounds having plethora of applications in anticancer drug development. These synthetic sources serve as the potent class of compounds in treatment of breast cancer, myeloid leukemia, pancreatic cancer, liver cancer and idiopathic respiratory fibrosis etc. The present review enumerates the results of studies published during past three years (2019–2021) on pyridine and pyrimidine analogues with their respective anticancer properties characterized in vitro or through in silico studies and illustrates their potential in development of anticancer agents. Recent advances on pyridine and pyrimidine analogues mentioned in this review add to the appealing opportunities for cancer therapy.</description><identifier>ISSN: 1878-5352</identifier><identifier>EISSN: 1878-5379</identifier><identifier>DOI: 10.1016/j.arabjc.2022.103846</identifier><language>eng</language><publisher>Elsevier B.V</publisher><subject>Anticancer ; Drugs ; In silico ; In vitro ; Pyridine ; Pyrimidine</subject><ispartof>Arabian journal of chemistry, 2022-06, Vol.15 (6), p.103846, Article 103846</ispartof><rights>2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c418t-42ec5f70b84a45bc64573fdef69b2fa0628ba1f9f0be62df895ab9a68faca0103</citedby><cites>FETCH-LOGICAL-c418t-42ec5f70b84a45bc64573fdef69b2fa0628ba1f9f0be62df895ab9a68faca0103</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1878535222001629$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3549,27924,27925,45780</link.rule.ids></links><search><creatorcontrib>Albratty, Mohammed</creatorcontrib><creatorcontrib>Alhazmi, Hassan Ahmad</creatorcontrib><title>Novel pyridine and pyrimidine derivatives as promising anticancer agents: A review</title><title>Arabian journal of chemistry</title><description>[Display omitted] Pyridines and pyrimidines are the class of heterocyclic nitrogenous compounds having plethora of applications in anticancer drug development. These synthetic sources serve as the potent class of compounds in treatment of breast cancer, myeloid leukemia, pancreatic cancer, liver cancer and idiopathic respiratory fibrosis etc. The present review enumerates the results of studies published during past three years (2019–2021) on pyridine and pyrimidine analogues with their respective anticancer properties characterized in vitro or through in silico studies and illustrates their potential in development of anticancer agents. Recent advances on pyridine and pyrimidine analogues mentioned in this review add to the appealing opportunities for cancer therapy.</description><subject>Anticancer</subject><subject>Drugs</subject><subject>In silico</subject><subject>In vitro</subject><subject>Pyridine</subject><subject>Pyrimidine</subject><issn>1878-5352</issn><issn>1878-5379</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9kF9LwzAUxYMoOKffwId-gc0kTZPWB2EM_wyGguhzuElvRsrWjqRU9u3NVtmjT8k93PvjnEPIPaNzRpl8aOYQwDR2zinnScpLIS_IhJWqnBW5qi7P_4Jfk5sYG0oVpbmckM_3bsBttj8EX_sWM2jr07AbxxqDH6D3A8YMYrYP3c5H327SXu8ttBZDBhts-_iYLbKAg8efW3LlYBvx7u-dku-X56_l22z98bpaLtYzK1jZzwRHWzhFTSlAFMZKUajc1ehkZbgDKnlpgLnKUYOS166sCjAVyNKBBZpCTslq5NYdNHqfPEM46A68Pgld2GgIyeUWNXXSgjOCFUYJzlRFpROVSkKOtbWYWGJk2dDFGNCdeYzqY8e60WPH-tixHjtOZ0_jGaacKXvQ0XpMrdQ-oO2TEf8_4BdZkohj</recordid><startdate>202206</startdate><enddate>202206</enddate><creator>Albratty, Mohammed</creator><creator>Alhazmi, Hassan Ahmad</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>DOA</scope></search><sort><creationdate>202206</creationdate><title>Novel pyridine and pyrimidine derivatives as promising anticancer agents: A review</title><author>Albratty, Mohammed ; Alhazmi, Hassan Ahmad</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c418t-42ec5f70b84a45bc64573fdef69b2fa0628ba1f9f0be62df895ab9a68faca0103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Anticancer</topic><topic>Drugs</topic><topic>In silico</topic><topic>In vitro</topic><topic>Pyridine</topic><topic>Pyrimidine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Albratty, Mohammed</creatorcontrib><creatorcontrib>Alhazmi, Hassan Ahmad</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Arabian journal of chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Albratty, Mohammed</au><au>Alhazmi, Hassan Ahmad</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Novel pyridine and pyrimidine derivatives as promising anticancer agents: A review</atitle><jtitle>Arabian journal of chemistry</jtitle><date>2022-06</date><risdate>2022</risdate><volume>15</volume><issue>6</issue><spage>103846</spage><pages>103846-</pages><artnum>103846</artnum><issn>1878-5352</issn><eissn>1878-5379</eissn><abstract>[Display omitted] Pyridines and pyrimidines are the class of heterocyclic nitrogenous compounds having plethora of applications in anticancer drug development. These synthetic sources serve as the potent class of compounds in treatment of breast cancer, myeloid leukemia, pancreatic cancer, liver cancer and idiopathic respiratory fibrosis etc. The present review enumerates the results of studies published during past three years (2019–2021) on pyridine and pyrimidine analogues with their respective anticancer properties characterized in vitro or through in silico studies and illustrates their potential in development of anticancer agents. Recent advances on pyridine and pyrimidine analogues mentioned in this review add to the appealing opportunities for cancer therapy.</abstract><pub>Elsevier B.V</pub><doi>10.1016/j.arabjc.2022.103846</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1878-5352
ispartof Arabian journal of chemistry, 2022-06, Vol.15 (6), p.103846, Article 103846
issn 1878-5352
1878-5379
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_0f6cafb415b74217906f497b413edcce
source ScienceDirect®; Full-Text Journals in Chemistry (Open access)
subjects Anticancer
Drugs
In silico
In vitro
Pyridine
Pyrimidine
title Novel pyridine and pyrimidine derivatives as promising anticancer agents: A review
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T23%3A01%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Novel%20pyridine%20and%20pyrimidine%20derivatives%20as%20promising%20anticancer%20agents:%20A%20review&rft.jtitle=Arabian%20journal%20of%20chemistry&rft.au=Albratty,%20Mohammed&rft.date=2022-06&rft.volume=15&rft.issue=6&rft.spage=103846&rft.pages=103846-&rft.artnum=103846&rft.issn=1878-5352&rft.eissn=1878-5379&rft_id=info:doi/10.1016/j.arabjc.2022.103846&rft_dat=%3Celsevier_doaj_%3ES1878535222001629%3C/elsevier_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c418t-42ec5f70b84a45bc64573fdef69b2fa0628ba1f9f0be62df895ab9a68faca0103%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true